Why the study?
Does drug-eluting stent implantation reduce death, recurrent MI, or stent thrombosis compared to bare metal stents in patients with NSTEMI undergoing PCI?
Population
674 patients with non-ST-segment elevation myocardial infarction who underwent successful percutaneous…
Comparison
Drug-eluting stents (DES) (n=323) vs Bare metal stents (BMS) (n=351)
Design
Cohort
Follow-up
mean 1333 ± 659 days
Authors
Loading...
DES associated with similar long-term safety but lower TVR in NSTEMI PCI; leaves open whether randomized trials would confirm.
Does drug-eluting stent implantation reduce death, recurrent MI, or stent thrombosis compared to bare metal stents in patients with NSTEMI undergoing PCI?
In NSTEMI patients undergoing PCI, drug-eluting stents are as safe as bare metal stents at long-term follow-up (>3 years) and significantly reduce the need for target vessel revascularization.
Harjai et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: